MYCN and glioblastoma: Extended HLA class I LOH was detected in nine (14.5%) osteosarcoma and four (18.2%) GBM, but not in aRMS, neuroblastoma MYCN-A and 11qLOH, nephroblastoma, and LGG tumors.